Clinical Trial Update: Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Update on a phase 1/2 clinical trial evaluating autologous bone marrow stem cells for spinal cord injury, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous bone marrow stem cells (autologous bone marrow stem cells)

Snippet

Sponsor: International Stemcell Services Limited | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED